Accelerated Approval Reforms Give US FDA More Power And Flexibility – With Some Gaps
Executive Summary
Pending legislation will give agency ability to require that confirmatory studies be underway at time of approval and expedited withdrawal process could allow FDA to skip a second advisory committee meeting, but Congress holds back on some agency requests for expanded authority.